Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Adicet Bio, Inc. (ACET) had Normalized Pre-Tax Income of $-20.24M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-20.24M |
|
-- |
|
-- |
|
$21.57M |
|
$-21.57M |
|
$1.33M |
|
$-20.24M |
|
|
Normalized Pre-Tax Income |
$-20.24M |
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-21.57M |
|
$-21.02M |
|
10.74M |
|
10.74M |
|
$-1.88 |
|
$-1.88 |
|
| Balance Sheet Financials | |
$140.07M |
|
$15.18M |
|
$29.31M |
|
$169.38M |
|
$18.30M |
|
$0.86M |
|
$11.02M |
|
$29.32M |
|
$140.06M |
|
$140.06M |
|
$140.06M |
|
9.60M |
|
| Cash Flow Statement Financials | |
$-21.49M |
|
$18.88M |
|
$-0.07M |
|
$41.79M |
|
$39.11M |
|
$-2.68M |
|
$1.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.66 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.45% |
|
-14.45% |
|
-11.95% |
|
-14.37% |
|
$14.59 |
|
$-2.00 |
|
$-2.00 |
|